Zimmer Biomet Holdings (ZBH) Misses Q3 EPS by 4c, Miss on Revenues; Lowers FY17 EPS Guidance Below Consensus; FY17 Revenue Outlook Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NYSE: ZBH) | Delayed: 98.81 +3.95 (4.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $94.86 | 52 Week High | $133.21 | |||
| Open | $95.96 | 52 Week Low | $88.27 | |||
| Day High | $98.92 | P/E | N/A | |||
| Day Low | $95.43 | EPS | $0.00 | |||
| Volume | 2,224,196 | |||||
